Dr. Alfio Comis Joins The Prestigious Ranks Of Stanford Who's Who
Dr. Alfio Comis has been accepted among the prestigious ranks of Stanford Who's Who as a result of his outstanding professional career.

DARLINGTON, SA, AUSTRALIA, August 17, 2011 /Stanford Who's Who/ -- Dr. Alfio Comis has been accepted among the prestigious ranks of Stanford Who's Who as a result of his outstanding professional career. As CEO and Managing Scientist of AusMAb (Australian Monoclonal Antibodies), as well as throughout his brilliant career, Dr. Comis has consistently displayed the passion, vision and dedication necessary to be considered among the best.

AusMAb is a state-of-the-art facility involved in the development of hybridoma cell lines and the purification of monoclonal antibodies. The company continues the tradition of MAbSA technologies with a cost-effective and high quality service with clients throughout Australia and overseas. They offer a wide variety of tissue culture services that are designed to produce an antibody product that is the perfect reagent for their clients' applications.

Dr. Comis is an expert in hybridoma technology with 35 years of professional experience. He is responsible for managing all major aspects of the business as well as overseeing the daily operations. During his collegiate career, he earned a PhD in Biochemistry from the University of Sydney.

To view more information on Dr. Alfio Comis click here

To visit the AusMAb website click here

Press Release Contact Information:

Christine Curcio
Stanford Who's Who
Public Relations
410 Park Avenue, 15th Floor
New York, NY
USA 10022
Voice: (877) 650-2140
Website: Visit Our Website